Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
IS

NASDAQ · ISPC

iSpecimen Inc.

Healthcare · Medical - Diagnostics & Research

$0.84

Up+$0.05 (+6.75%)

Updated Nov 5, 2026, 4:42 AM

SID Score

4.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.64M
P/E ratio
-0.24
Dividend yield
0.00%
52-week range
$0.10 – $7.29
Volume
168.22K
Avg. volume
1.91M

Price performance · ISPC

ISPC price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 4, 2026

ISPC closed at $0.84 after 21 trading sessions, down 23.36% for the selected period.

Last close
$0.84
Period change
-23.36%
Period low
$0.79
Period high
$1.13
Daily close
View OHLC price history
ISPC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 4, 2026$0.83$0.8969$0.7855$0.843168.22K
Nov 3, 2026$0.8241$0.9576$0.7682$0.7897506.98K
Nov 2, 2026$0.8255$0.8398$0.754$0.8323108.48K
Oct 30, 2026$0.845$0.8699$0.753$0.8255543.34K
Oct 29, 2026$0.841$0.94$0.7923$0.79232.59M
Oct 28, 2026$0.87$0.874$0.8401$0.87430.65K
Oct 27, 2026$0.8336$0.8907$0.81$0.872149.12K
Oct 26, 2026$0.802$0.87$0.791$0.839866.42K
Oct 23, 2026$0.80$0.83$0.7886$0.81740.09K
Oct 22, 2026$0.83$0.8571$0.813$0.832773.59K
Oct 21, 2026$0.9262$0.9499$0.875$0.892572.52K
Oct 20, 2026$0.94$0.9949$0.8901$0.9599235.52K
Oct 19, 2026$0.917$0.9588$0.90$0.9101827.13K
Oct 16, 2026$1.02$1.02$0.9101$0.91747.53K
Oct 15, 2026$0.98$1.0499$0.97$1.03100.69K
Oct 14, 2026$1.0699$1.07$1.02$1.0267.4K
Oct 13, 2026$1.07$1.10$1.0313$1.0869.76K
Oct 12, 2026$1.12$1.132$1.055$1.0845.1K
Oct 9, 2026$1.10$1.15$1.10$1.1372.02K
Oct 8, 2026$1.09$1.13$1.07$1.0971.25K
Oct 7, 2026$1.07$1.1099$1.0501$1.1055.13K

Latest ISPC news

The latest Smart Investors Daily articles mentioning ISPC.

Stock researchCompany · Overview

ISPC research

Overview

Company profile and research snapshot.

Company profile

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
ISPC recent ratings
DateFirmRatingTarget
Sep 23, 2022EF HuttonBuy—
Jan 4, 2022Craig-HallumBuy—
Nov 22, 2021EF HuttonBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 29, 2026

iSpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent

Woburn, Massachusetts--(Newsfile Corp. - October 29, 2026) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), a provider of human biospecimens, today announced expanded access to fully consented, prospectively collected healthy donor whole blood through an existing collection partner.The expanded capability gives researchers a streamlined option for sourcing whole blood collected specifically for research. Specimens are generally shipped directly from the collection site on the day.

Yahoo · Sep 29, 2026

iSpecimen Supports Hospital Validation of New Chemistry Analyzer

Company coordinates collection of more than 1,700 human specimens to support new laboratory testing capabilitiesWoburn, Massachusetts--(Newsfile Corp. - September 29, 2026) - iSpecimen, a provider of human biospecimens, is supporting a hospital laboratory in the validation of a new chemistry analyzer for clinical use. For the project, iSpecimen identified a healthcare system already using the same analyzer and is coordinating the collection of more than 1,700 serum, plasma, cerebrospinal fluid..

Benzinga · Sep 8, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million. Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By